ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 556 filers reported holding ASTRAZENECA PLC in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $664,461 | -8.8% | 9,812 | -3.6% | 0.02% | -4.0% |
| Q2 2023 | $728,261 | +5.8% | 10,177 | +2.6% | 0.02% | 0.0% |
| Q1 2023 | $688,654 | -9.1% | 9,923 | -11.2% | 0.02% | -16.7% |
| Q4 2022 | $757,684 | +47.7% | 11,177 | +19.5% | 0.03% | +36.4% |
| Q3 2022 | $513,000 | +29.2% | 9,350 | +55.8% | 0.02% | +37.5% |
| Q2 2022 | $397,000 | +4.7% | 6,003 | +5.2% | 0.02% | +14.3% |
| Q1 2022 | $379,000 | +17.7% | 5,707 | +3.2% | 0.01% | +16.7% |
| Q4 2021 | $322,000 | -3.0% | 5,531 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $332,000 | +0.3% | 5,531 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $331,000 | -14.9% | 5,531 | -29.2% | 0.01% | -17.6% |
| Q1 2021 | $389,000 | -0.5% | 7,816 | 0.0% | 0.02% | -15.0% |
| Q4 2020 | $391,000 | -8.6% | 7,816 | 0.0% | 0.02% | -20.0% |
| Q3 2020 | $428,000 | +3.6% | 7,816 | 0.0% | 0.02% | -3.8% |
| Q2 2020 | $413,000 | +18.3% | 7,816 | 0.0% | 0.03% | -3.7% |
| Q1 2020 | $349,000 | -17.7% | 7,816 | -8.2% | 0.03% | 0.0% |
| Q4 2019 | $424,000 | +11.0% | 8,511 | -0.7% | 0.03% | 0.0% |
| Q3 2019 | $382,000 | +36.9% | 8,571 | +26.6% | 0.03% | +35.0% |
| Q2 2019 | $279,000 | +1.8% | 6,771 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $274,000 | +2.6% | 6,771 | -3.6% | 0.02% | -9.1% |
| Q4 2018 | $267,000 | +4.7% | 7,021 | +8.8% | 0.02% | +15.8% |
| Q3 2018 | $255,000 | -2.7% | 6,455 | -13.4% | 0.02% | -9.5% |
| Q2 2018 | $262,000 | -19.1% | 7,455 | -19.4% | 0.02% | -19.2% |
| Q1 2018 | $324,000 | -14.7% | 9,255 | -15.5% | 0.03% | -18.8% |
| Q4 2017 | $380,000 | +2.4% | 10,955 | 0.0% | 0.03% | -5.9% |
| Q3 2017 | $371,000 | +17.8% | 10,955 | +18.4% | 0.03% | +13.3% |
| Q2 2017 | $315,000 | +22.1% | 9,255 | +11.6% | 0.03% | +15.4% |
| Q1 2017 | $258,000 | +13.7% | 8,295 | 0.0% | 0.03% | +8.3% |
| Q4 2016 | $227,000 | -27.5% | 8,295 | -13.1% | 0.02% | -33.3% |
| Q3 2016 | $313,000 | +8.7% | 9,540 | 0.0% | 0.04% | +9.1% |
| Q2 2016 | $288,000 | -12.7% | 9,540 | -18.6% | 0.03% | -15.4% |
| Q1 2016 | $330,000 | -17.1% | 11,720 | 0.0% | 0.04% | -17.0% |
| Q4 2015 | $398,000 | +6.4% | 11,720 | -0.4% | 0.05% | +2.2% |
| Q3 2015 | $374,000 | -8.1% | 11,770 | +84.3% | 0.05% | +2.2% |
| Q2 2015 | $407,000 | -6.9% | 6,385 | 0.0% | 0.04% | -6.2% |
| Q1 2015 | $437,000 | -2.7% | 6,385 | 0.0% | 0.05% | -4.0% |
| Q4 2014 | $449,000 | -1.5% | 6,385 | 0.0% | 0.05% | -3.8% |
| Q3 2014 | $456,000 | -3.8% | 6,385 | 0.0% | 0.05% | -1.9% |
| Q2 2014 | $474,000 | +14.5% | 6,385 | 0.0% | 0.05% | +8.2% |
| Q1 2014 | $414,000 | -5.9% | 6,385 | -13.8% | 0.05% | -7.5% |
| Q4 2013 | $440,000 | +5.0% | 7,410 | -8.1% | 0.05% | -5.4% |
| Q3 2013 | $419,000 | +3.5% | 8,060 | -5.8% | 0.06% | -3.4% |
| Q2 2013 | $405,000 | – | 8,560 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |